Rating Change
BTIG analysts reiterated a Buy rating on Astrana Health, Inc. (NASDAQ:ASTH) on July 14, 2026.
reiterateNASDAQ:ASTH
BTIG Reiterates Buy Rating on Astrana Health, Inc. (ASTH)
Rating Change BTIG analysts reiterated a Buy rating on Astrana Health, Inc. (NASDAQ:ASTH) on July 14, 2026. Market Context Astrana Health, Inc.
Market Context
Astrana Health, Inc. operates in the Healthcare sector. The stock currently trades at $49.00 with a market capitalization of $1.0B.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Astrana Health, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Astrana Health, Inc.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 14, 2026 | TD Cowen | Buy | N/A |
| Jul 14, 2026 | BTIG | Buy | N/A |
| Jun 02, 2026 | BTIG | Buy | N/A |
| May 26, 2026 | Barclays | Overweight | N/A |
| May 14, 2026 | Truist Securities | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View ASTH Stock Page
Frequently Asked Questions
What does a Buy rating mean for ASTH?
A Buy rating from BTIG reflects the analyst's outlook on Astrana Health, Inc. (NASDAQ:ASTH). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ASTH forecast page.